Global healthcare cost pressures are expected to persist through\n2026, though the rate of increase is beginning to slow. A latest report\nfrom Aon indicates that the global average medical trend is projected at\n9.8% for 2026, down marginally from 10% the previous year and returning\nto single-digit levels for the first time since 2023.<\/p>\n
Despite this decline, global medical trend remains far above general\nglobal inflation of around 2.7%, meaning healthcare costs are rising\napproximately three to four times faster than economic inflation\noverall.<\/p>\n
Indonesia remains among countries experiencing high medical inflation\npressure. Aon estimates Indonesia\u2019s medical trend at 16.9% for 2026,\nsignificantly above the global average despite general inflation running\nat only around 2.5%.<\/p>\n
Medical trend represents the projected annual healthcare cost\nincreases influenced by medical inflation, increased service\nutilisation, drug prices, and healthcare technology innovation. In\nrecent years, these factors have continued to sustain high healthcare\ncosts across many countries.<\/p>\n
Regionally, the Middle East and Africa record the highest healthcare\ncost increase projections with a medical trend of 15.3%, followed by the\nAsia-Pacific region at 11.3%, whilst Europe has the lowest projection at\naround 8.2%.<\/p>\n
From an epidemiological perspective, cardiovascular disease, cancer,\nand hypertension remain the primary contributors to global healthcare\nclaims. Risk factors including poor diet, physical inactivity, and\nobesity further increase healthcare cost burdens across many\ncountries.<\/p>\n
Additionally, the report highlights the growing role of innovative\ndrugs such as GLP-1 used for diabetes and weight management. In several\nmarkets, use of this drug has contributed up to one quarter of drug cost\nincreases within corporate health programmes.<\/p>\n
Facing these trends, global companies are increasingly aggressive in\ncost control. Strategies employed include strengthening wellness\nprogrammes, negotiating rates with insurance companies, and implementing\nflexible benefit designs and employee cost-sharing schemes.<\/p>\n
Despite the rate of cost increases beginning to moderate, Aon\nbelieves structural pressures such as population ageing, adoption of\nmedical technology, and rising demand for private healthcare services\nwill keep medical inflation a major challenge for companies and\nhealthcare benefit administrators in coming years.<\/p>\n
High medical inflation in Indonesia is triggered by a combination of\nthree main factors. First, the rising burden of chronic diseases such as\ncardiovascular disease, cancer, and hypertension, driving demand for\nlong-term and high-cost care.<\/p>\n
Secondly, a surge in healthcare service utilisation accompanying\nmiddle-class growth, expansion of commercial health insurance, and\nprivate hospital expansion, causing claim volumes to increase\nrapidly.<\/p>\n
Thirdly, escalating service and medical technology costs, including\nuse of innovative therapies and expensive medicines, further driving\nper-episode treatment cost increases.<\/p>\n
Unlike several ASEAN countries (Singapore and Thailand) with stronger\ncost control mechanisms, Indonesia remains in a healthcare system\ntransition phase. The combination of rising demand, private service\ntariffs, and changing disease profiles makes national medical inflation\ngrow faster than neighbouring countries.<\/p>\n
This condition is expected to continue pressuring commercial health\ninsurance premiums whilst driving the industry to adjust benefit designs\nin coming years.<\/p>\n
Consistent high-level medical inflation increases are projected to\nhave direct implications for commercial health insurance premiums.<\/p>\n
Insurance companies are projected to become increasingly aggressive\nin product design adjustments through co-payment schemes, deductibles,\nprovider network strengthening, and health management programmes.<\/p>\n
More broadly, this trend also signals that controlling medical\ninflation will become a strategic agenda for Indonesia\u2019s healthcare\nindustry in coming years, as the private sector\u2019s role in healthcare\nfinancing expands.<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/global-medical-inflation-gap-widens-indonesia-in-focus-1773039213", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }